Skip to main content

Brain Death clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for
  • Intravenous Thyroxine for Heart-Eligible Organ Donors

    open to eligible people ages 14-55

    This randomized controlled trial will evaluate whether intravenous thyroxine infusion given to brain-dead organ donors who are eligible to donate hearts for 12 hours will result in more hearts transplanted than saline placebo

    at UCSD

  • Deceased Organ Donor Interventions to Protect Kidney Graft Function

    Sorry, in progress, not accepting new patients

    To protect kidney function during the transplantation process by comparing mild hypothermia in the deceased organ donor before organs are recovered and pulsatile perfusion of the kidney after recovery and prior to transplantation.

    at UCSF

Last updated: